{"id":1863,"date":"2026-01-16T06:08:02","date_gmt":"2026-01-16T06:08:02","guid":{"rendered":"https:\/\/amm-journal.org\/?p=1863"},"modified":"2026-01-16T06:16:28","modified_gmt":"2026-01-16T06:16:28","slug":"drug-rd-ai-drug-design-precision-medicine","status":"publish","type":"post","link":"https:\/\/amm-journal.org\/index.php\/2026\/01\/16\/drug-rd-ai-drug-design-precision-medicine\/","title":{"rendered":"How new drug R&#038;D can solve intractable scientific problems and meet clinical needs: insights from analysis of typical use cases"},"content":{"rendered":"<p>Announcing a new publication for <a href=\"https:\/\/amm-journal.org\/\"><em>Acta Materia Medica<\/em><\/a> journal. \u00a0New drug research and development (R&amp;D) faces critical challenges such as drug resistance, ineffectiveness of single-target interventions, \u201cundruggable\u201d targets, long cycles, and high costs. This article analyzes five typical use cases to illustrate breakthrough strategies for addressing these issues.<\/p>\n<p>Innovations include the identification of dual-target antibiotics (paenimicin) and phospholipid-targeting antifungals (mandimycin) that overcome microbial resistance via mining silent biosynthetic gene clusters; development of \u201cmolecular glue\u201d compounds (D927 and BBO-10203) that regulate protein-protein interactions, thus addressing insulin resistance and tumor drug resistance; AI-driven discovery of the TNIK inhibitor rentosertib for reversing pulmonary fibrosis; use of protein interface remodeling to develop the KRAS G12D inhibitor zoldonrasib for \u201cundruggable\u201d targets; and repurposing of existing drug combinations (letrozole plus irinotecan), on the basis of multi-omics data for Alzheimer\u2019s disease.<\/p>\n<p>These use cases demonstrate how interdisciplinary technologies (e.g., AI and structural biology) and strategic innovations (multi-target design and drug repurposing) can drive a transformation from experience-driven to precision and intelligence-driven R&amp;D, and provides a reference for meeting intractable clinical needs.<\/p>\n<p>Read More:\u00a0<a href=\"https:\/\/www.scienceopen.com\/hosted-document?doi=10.15212\/AMM-2025-0054\">https:\/\/www.scienceopen.com\/hosted-document?doi=10.15212\/AMM-2025-0054<\/a><\/p>\n<p><a href=\"https:\/\/amm-journal.org\/\"><em>Acta Materia Medica<\/em><\/a> welcomes the submission of research articles, review articles, databases, mini reviews, commentaries, editorials, short communications, case report articles and study protocols.<\/p>\n<p><strong>Submission Process<\/strong><\/p>\n<p>Submissions <em>to Acta Materia Medica<\/em> are made using ScholarOne, the online submission and peer review system. Registration and access are available at <a href=\"https:\/\/mc04.manuscriptcentral.com\/ammed\">https:\/\/mc04.manuscriptcentral.com\/ammed<\/a><\/p>\n<p>Queries about the journal can be sent to editorialoffice@amm-journal.org.<\/p>\n<p>Please visit <a href=\"https:\/\/amm-journal.org\/\">https:\/\/amm-journal.org\/<\/a> to learn more about the journal.<\/p>\n<p><strong>Editorial Board:<\/strong> <a href=\"https:\/\/amm-journal.org\/index.php\/editorial-board\/\">https:\/\/amm-journal.org\/index.php\/editorial-board\/<\/a><\/p>\n<p>There are no author submission or article processing fees.<\/p>\n<p>Follow <strong><em>Acta Materia Medica <\/em><\/strong>on Twitter <a href=\"https:\/\/twitter.com\/AMM_journal\">https:\/\/twitter.com\/AMM_journal<\/a>; <a href=\"https:\/\/www.facebook.com\/Zoonoses-Journal-100462755574114\">Facebook<\/a> (<a href=\"https:\/\/www.facebook.com\/AMMjournal\">https:\/\/www.facebook.com\/AMMjournal<\/a>)<\/p>\n<p><strong>eISSN <\/strong>2737-7946<\/p>\n<p>Mei Wang, Kai Song and Haiyong Jia et al. How new drug R&amp;D can solve intractable scientific problems and meet clinical needs: insights from analysis of typical use cases.\u00a0<em>Acta Materia Medica.\u00a0<\/em>2026. Vol. 5(1):1-7. DOI: 10.15212\/AMM-2025-0054<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Announcing a new publication for Acta Materia Medica journal. \u00a0New drug research and development (R&amp;D) faces critical challenges such as drug resistance, ineffectiveness of single-target interventions, \u201cundruggable\u201d targets, long cycles, and high costs. This article analyzes five typical use cases to illustrate breakthrough strategies for addressing these issues. Innovations include the identification of dual-target antibiotics [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":1864,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[549,482,550,551],"class_list":["post-1863","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-and-events","tag-drug-rd","tag-drug-resistance","tag-precison-medicine","tag-undruggable-targets"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>How new drug R&amp;D can solve intractable scientific problems and meet clinical needs: insights from analysis of typical use cases<\/title>\n<meta name=\"description\" content=\"Illustrating breakthrough strategies against challenges in drug R&amp;D, showing how interdisciplinary approach &amp; strategic innovation drive precision medicine.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/amm-journal.org\/index.php\/2026\/01\/16\/drug-rd-ai-drug-design-precision-medicine\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"How new drug R&amp;D can solve intractable scientific problems and meet clinical needs: insights from analysis of typical use cases\" \/>\n<meta property=\"og:description\" content=\"Illustrating breakthrough strategies against challenges in drug R&amp;D, showing how interdisciplinary approach &amp; strategic innovation drive precision medicine.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/amm-journal.org\/index.php\/2026\/01\/16\/drug-rd-ai-drug-design-precision-medicine\/\" \/>\n<meta property=\"og:site_name\" content=\"AMM Journal\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-16T06:08:02+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-16T06:16:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/amm-journal.org\/wp-content\/uploads\/2026\/01\/How-new-drug-RD.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"628\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Suresh PDMR\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Suresh PDMR\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2026\\\/01\\\/16\\\/drug-rd-ai-drug-design-precision-medicine\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2026\\\/01\\\/16\\\/drug-rd-ai-drug-design-precision-medicine\\\/\"},\"author\":{\"name\":\"Suresh PDMR\",\"@id\":\"https:\\\/\\\/amm-journal.org\\\/#\\\/schema\\\/person\\\/36ab5fda177218467d112d0c1283065e\"},\"headline\":\"How new drug R&#038;D can solve intractable scientific problems and meet clinical needs: insights from analysis of typical use cases\",\"datePublished\":\"2026-01-16T06:08:02+00:00\",\"dateModified\":\"2026-01-16T06:16:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2026\\\/01\\\/16\\\/drug-rd-ai-drug-design-precision-medicine\\\/\"},\"wordCount\":362,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2026\\\/01\\\/16\\\/drug-rd-ai-drug-design-precision-medicine\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/amm-journal.org\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/How-new-drug-RD.png\",\"keywords\":[\"drug R&amp;D\",\"drug resistance\",\"precison medicine\",\"undruggable targets\"],\"articleSection\":[\"News and Events\"],\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2026\\\/01\\\/16\\\/drug-rd-ai-drug-design-precision-medicine\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2026\\\/01\\\/16\\\/drug-rd-ai-drug-design-precision-medicine\\\/\",\"url\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2026\\\/01\\\/16\\\/drug-rd-ai-drug-design-precision-medicine\\\/\",\"name\":\"How new drug R&D can solve intractable scientific problems and meet clinical needs: insights from analysis of typical use cases\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/amm-journal.org\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2026\\\/01\\\/16\\\/drug-rd-ai-drug-design-precision-medicine\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2026\\\/01\\\/16\\\/drug-rd-ai-drug-design-precision-medicine\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/amm-journal.org\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/How-new-drug-RD.png\",\"datePublished\":\"2026-01-16T06:08:02+00:00\",\"dateModified\":\"2026-01-16T06:16:28+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/amm-journal.org\\\/#\\\/schema\\\/person\\\/36ab5fda177218467d112d0c1283065e\"},\"description\":\"Illustrating breakthrough strategies against challenges in drug R&D, showing how interdisciplinary approach & strategic innovation drive precision medicine.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2026\\\/01\\\/16\\\/drug-rd-ai-drug-design-precision-medicine\\\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2026\\\/01\\\/16\\\/drug-rd-ai-drug-design-precision-medicine\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2026\\\/01\\\/16\\\/drug-rd-ai-drug-design-precision-medicine\\\/#primaryimage\",\"url\":\"https:\\\/\\\/amm-journal.org\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/How-new-drug-RD.png\",\"contentUrl\":\"https:\\\/\\\/amm-journal.org\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/How-new-drug-RD.png\",\"width\":1200,\"height\":628},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2026\\\/01\\\/16\\\/drug-rd-ai-drug-design-precision-medicine\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/amm-journal.org\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"How new drug R&#038;D can solve intractable scientific problems and meet clinical needs: insights from analysis of typical use cases\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/amm-journal.org\\\/#website\",\"url\":\"https:\\\/\\\/amm-journal.org\\\/\",\"name\":\"AMM Journal\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/amm-journal.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/amm-journal.org\\\/#\\\/schema\\\/person\\\/36ab5fda177218467d112d0c1283065e\",\"name\":\"Suresh PDMR\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/78f026916ecafc09393a244fb16a944cf7ed125822beafb24d190ab4192ca56c?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/78f026916ecafc09393a244fb16a944cf7ed125822beafb24d190ab4192ca56c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/78f026916ecafc09393a244fb16a944cf7ed125822beafb24d190ab4192ca56c?s=96&d=mm&r=g\",\"caption\":\"Suresh PDMR\"},\"url\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/author\\\/suresh\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"How new drug R&D can solve intractable scientific problems and meet clinical needs: insights from analysis of typical use cases","description":"Illustrating breakthrough strategies against challenges in drug R&D, showing how interdisciplinary approach & strategic innovation drive precision medicine.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/amm-journal.org\/index.php\/2026\/01\/16\/drug-rd-ai-drug-design-precision-medicine\/","og_locale":"en_GB","og_type":"article","og_title":"How new drug R&D can solve intractable scientific problems and meet clinical needs: insights from analysis of typical use cases","og_description":"Illustrating breakthrough strategies against challenges in drug R&D, showing how interdisciplinary approach & strategic innovation drive precision medicine.","og_url":"https:\/\/amm-journal.org\/index.php\/2026\/01\/16\/drug-rd-ai-drug-design-precision-medicine\/","og_site_name":"AMM Journal","article_published_time":"2026-01-16T06:08:02+00:00","article_modified_time":"2026-01-16T06:16:28+00:00","og_image":[{"width":1200,"height":628,"url":"https:\/\/amm-journal.org\/wp-content\/uploads\/2026\/01\/How-new-drug-RD.png","type":"image\/png"}],"author":"Suresh PDMR","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Suresh PDMR","Estimated reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/amm-journal.org\/index.php\/2026\/01\/16\/drug-rd-ai-drug-design-precision-medicine\/#article","isPartOf":{"@id":"https:\/\/amm-journal.org\/index.php\/2026\/01\/16\/drug-rd-ai-drug-design-precision-medicine\/"},"author":{"name":"Suresh PDMR","@id":"https:\/\/amm-journal.org\/#\/schema\/person\/36ab5fda177218467d112d0c1283065e"},"headline":"How new drug R&#038;D can solve intractable scientific problems and meet clinical needs: insights from analysis of typical use cases","datePublished":"2026-01-16T06:08:02+00:00","dateModified":"2026-01-16T06:16:28+00:00","mainEntityOfPage":{"@id":"https:\/\/amm-journal.org\/index.php\/2026\/01\/16\/drug-rd-ai-drug-design-precision-medicine\/"},"wordCount":362,"commentCount":0,"image":{"@id":"https:\/\/amm-journal.org\/index.php\/2026\/01\/16\/drug-rd-ai-drug-design-precision-medicine\/#primaryimage"},"thumbnailUrl":"https:\/\/amm-journal.org\/wp-content\/uploads\/2026\/01\/How-new-drug-RD.png","keywords":["drug R&amp;D","drug resistance","precison medicine","undruggable targets"],"articleSection":["News and Events"],"inLanguage":"en-GB","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/amm-journal.org\/index.php\/2026\/01\/16\/drug-rd-ai-drug-design-precision-medicine\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/amm-journal.org\/index.php\/2026\/01\/16\/drug-rd-ai-drug-design-precision-medicine\/","url":"https:\/\/amm-journal.org\/index.php\/2026\/01\/16\/drug-rd-ai-drug-design-precision-medicine\/","name":"How new drug R&D can solve intractable scientific problems and meet clinical needs: insights from analysis of typical use cases","isPartOf":{"@id":"https:\/\/amm-journal.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/amm-journal.org\/index.php\/2026\/01\/16\/drug-rd-ai-drug-design-precision-medicine\/#primaryimage"},"image":{"@id":"https:\/\/amm-journal.org\/index.php\/2026\/01\/16\/drug-rd-ai-drug-design-precision-medicine\/#primaryimage"},"thumbnailUrl":"https:\/\/amm-journal.org\/wp-content\/uploads\/2026\/01\/How-new-drug-RD.png","datePublished":"2026-01-16T06:08:02+00:00","dateModified":"2026-01-16T06:16:28+00:00","author":{"@id":"https:\/\/amm-journal.org\/#\/schema\/person\/36ab5fda177218467d112d0c1283065e"},"description":"Illustrating breakthrough strategies against challenges in drug R&D, showing how interdisciplinary approach & strategic innovation drive precision medicine.","breadcrumb":{"@id":"https:\/\/amm-journal.org\/index.php\/2026\/01\/16\/drug-rd-ai-drug-design-precision-medicine\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/amm-journal.org\/index.php\/2026\/01\/16\/drug-rd-ai-drug-design-precision-medicine\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/amm-journal.org\/index.php\/2026\/01\/16\/drug-rd-ai-drug-design-precision-medicine\/#primaryimage","url":"https:\/\/amm-journal.org\/wp-content\/uploads\/2026\/01\/How-new-drug-RD.png","contentUrl":"https:\/\/amm-journal.org\/wp-content\/uploads\/2026\/01\/How-new-drug-RD.png","width":1200,"height":628},{"@type":"BreadcrumbList","@id":"https:\/\/amm-journal.org\/index.php\/2026\/01\/16\/drug-rd-ai-drug-design-precision-medicine\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/amm-journal.org\/"},{"@type":"ListItem","position":2,"name":"How new drug R&#038;D can solve intractable scientific problems and meet clinical needs: insights from analysis of typical use cases"}]},{"@type":"WebSite","@id":"https:\/\/amm-journal.org\/#website","url":"https:\/\/amm-journal.org\/","name":"AMM Journal","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/amm-journal.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Person","@id":"https:\/\/amm-journal.org\/#\/schema\/person\/36ab5fda177218467d112d0c1283065e","name":"Suresh PDMR","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/secure.gravatar.com\/avatar\/78f026916ecafc09393a244fb16a944cf7ed125822beafb24d190ab4192ca56c?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/78f026916ecafc09393a244fb16a944cf7ed125822beafb24d190ab4192ca56c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/78f026916ecafc09393a244fb16a944cf7ed125822beafb24d190ab4192ca56c?s=96&d=mm&r=g","caption":"Suresh PDMR"},"url":"https:\/\/amm-journal.org\/index.php\/author\/suresh\/"}]}},"_links":{"self":[{"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/posts\/1863","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/comments?post=1863"}],"version-history":[{"count":1,"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/posts\/1863\/revisions"}],"predecessor-version":[{"id":1865,"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/posts\/1863\/revisions\/1865"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/media\/1864"}],"wp:attachment":[{"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/media?parent=1863"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/categories?post=1863"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/tags?post=1863"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}